Log in

Familial aggregation of melanoma risks in a large population-based sample of melanoma cases

  • Published:
Cancer Causes & Control Aims and scope Submit manuscript

Abstract

ObjectiveMelanoma has been shown in numerous studies to be associated with sun exposure, and with host phenotypic factors of genetic origin. In this study we use information from a large series of incident cases of melanoma from an international population-based study to examine the patterns of incidence of melanoma in the first-degree relatives of these cases. Methods: A total of 2508 incident cases of melanoma provided information on basic demographic data and pigmentary characteristics, in addition to detailed information on family history of melanoma. These data were used to examine the incidence rates ratios of melanoma in the relatives of cases in relation to population rates, and also with respect to phenotypic characteristics of the probands that have been shown to be associated with melanoma: mole counts, hair color, eye color, and skin sensitivity to the sun. Results: The incidence rates reflect the underlying patterns of incidence in the source populations, with generally higher rates in the Australian sample, low rates in Italy, and intermediate rates in the USA and Canada. Also, rates are higher in men than in women, except at very young ages. Phenotypic characteristics of the probands were only weakly associated with the observed rates in the relatives although there is a strong inverse association with age at diagnosis. Cumulative risk of melanoma rises to 6.9 (6.1) at age 80 in male (female) first-degree relatives of cases, and to 10.8 (9.5) in relatives of cases diagnosed before age 50. Conclusions: Relatives of cases diagnosed with melanoma are at considerable lifetime risk of the disease, especially if the case is diagnosed at a young age.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Germany)

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Armstrong BK, Kricker A (1994) Cutaneous melanoma. In: Cancer Surveys Voume 19:Trends in Cancer Incidence and Mortality. Imperial Cancer Research Fund, London.

    Google Scholar 

  2. Boyle P, Maisonneuve P, Dore JF (1995) Epidemiology of malignant melanoma. Br Med Bull 51:523–547.

    Google Scholar 

  3. Elwood JM (1993) Recent developments in melanoma epidemiol-ogy, 1993. Melanoma Res 3:149–156.

    Google Scholar 

  4. Bliss JM, Ford D, Swerdlow AJ, et al. (1995) Risk of cutaneous melanoma associated with pigmentation characteristics and freck-ling:systematic overview of 10 case –control studies. Int J Cancer 62:367–376.

    Google Scholar 

  5. Kamb A, Gruis NA, Weaver-Feldhous J, et al. (1994) A cell cycle regulator potentially involved in genesis of many tumor types. Science 264:436–440.

    Google Scholar 

  6. Holland EA, Beaton SC, Becker TM, et al. (1995) Analysis of the p16 gene, CDKN2, in 17 Australian kindreds. Oncogene 11:2289–2294.

    Google Scholar 

  7. Goldstein AM, Tucker MA (2001) Genetic epidemiology of cutaneous melanoma:a global perspective. Arch Dermatol 137: 1493–1496.

    Google Scholar 

  8. Saunders CL, Begg CB (2003) Kin-cohort evaluation of relative risks of genetic variants. Genet Epidemiol 24:220–229.

    Google Scholar 

  9. Begg CB (2002) On the use of familial aggregation in population-based case probands for calculating penetrance. J Natl Cancer Inst 94:1221–1226.

    Google Scholar 

  10. Fitzpatrick TB (1975) Soleil et peau. J Med Esthet 2:33.

    Google Scholar 

  11. Ries LAG, Eisner MP, Kosary CL, et al. eds. (2002) SEER Cancer Statistics Review 1973 –1999, Bethesda, MD:National Cancer Institute. Also available from: URL:http://seer. cancer. gov/csr/ 1973–1999.

  12. Stata® (2001) Reference Manual, Release 7, College Station, Texas: Stata Press.

  13. Aitken JF, Duffy DL, Green A, Youl P, MacLennan R, Martin NG (1994) Heterogeneity of melanoma risk in families of melanoma patients. Am J Epidemiol 140:961–973.

    Google Scholar 

  14. Ford D, Bliss JM, Swerdlow AJ, et al. (1995) Risk of cutaneous melanoma associated with a family history of the disease. Int J Cancer 62:377–381.

    Google Scholar 

  15. Risch N (1990) Linkage strategies for genetically complex traits:I. multilocus models. Am J Hum Genet 46:222–228.

    Google Scholar 

  16. Hemminki K, Zhang H, Czene K (2003) Familial and attributable risks in cutaneous melanoma:effects of proband and age. J Invest Dermatol 120:217–223.

    Google Scholar 

  17. Begg CB (2001) The search for cancer risk factors:when can we stop looking? Am J Public Health 91:360–364.

    Google Scholar 

  18. Swerdlow AJ, Green A (1987) Melanocytic naevi and melanoma: an epidemiologic perspective. Br J Dermatol 117:137–146.

    Google Scholar 

  19. Swerdlow AJ, English J, Mackie RM, et al. (1986) Benign melanocytic naevi as a risk factor for melanoma. Br Med J 292: 1555–1559.

    Google Scholar 

  20. Holly EA, Kelly SW, Shpall SN, Chiu SH (1987) Number of melanocytic nevi as a major risk factor for malignant melanoma. J Am Acad Dermatol 17:459–468.

    Google Scholar 

  21. Roush GC, Norlund JJ, Forget B, Gruber SB, Kirkwood JM (1988) Independence of dysplastic nevi from total nevi in deter-mining risk for non-familial melanoma. Prev Med 17:273–279.

    Google Scholar 

  22. Grob JJ, Gouvernet J, Aymar D, et al. (1990) Count of benign melanocytic nevi as a major indicator of risk for non-familial nodular and super cial spreading melanoma. Cancer 66:387–395.

    Google Scholar 

  23. Augustsson A, Stierner U, Rosdahl I, Suurkula M(1990) Common and dysplastic naevi as risk factors for cutaneous malignant melanoma in Swedish population. Acta Derm Verereol 71: 518–524.

    Google Scholar 

  24. Kruger S, Garke C, Buttner P, Stadler R, Guggenmoos-Holzmann I, Orfaros C (1992) Epidemiologic evidence for the role of melanocytic nevi as risk markers and direct precursors of cutane-ous malignant melanoma. J Am Acad Dermatol 26:920–926.

    Google Scholar 

  25. Bataille V, Newton Bishop JA, Sasieni P, et al. (1996) Risk of cutaneous melanoma in relation to the numbers, types and sitzes of naevi:a case-control study. Br J Cancer 73:1605–1611.

    Google Scholar 

  26. Tucker MA, Halpern A, Holly EA, et al. (1997) Clinically recognized dysplastic nevi:a central risk factor for cutaneous melanoma. JAMA 277:1439–1444.

    Google Scholar 

  27. Brogelli L, DeGiorgi V, Bini F, Giannotti B (1991) Melanocytic naevi:clinical features and correlation with the phenotype in healthy young males in Italy. Br J Dermatol 125:349–352.

    Google Scholar 

  28. Dennis L, White E, Lee JAH, Kristal A, McKnight B, Odland P (1996) Constitutional factors and sun exposure in relation to nevi: a population-based cross-sectional study. Am J Epidemiol 143: 248–256.

    Google Scholar 

  29. Dennis LK, White E, McKnight B, Kristal A, Lee JAH, Odland P (1996) Nevi and migration within the United States and Canada:a population-based cross-sectional study. Cancer Causes Control 7: 464–473.

    Google Scholar 

  30. Carli P, Naldi L, Lovati S, LaVecchia C (1996) The density of melanocytic nevi correlates with constitutional variables and history of sunburns:a prevalence study among Italian schoolchil-dren. Int J Cancer 101:375–379.

    Google Scholar 

  31. Dulon M, Weichenthal M, Blettner M, et al. (2002) Sun exposure and number of nevi in 5-to 6-year old European children. J Clin Epidemiol 55:1075–1081.

    Google Scholar 

  32. Wiecker TS, Luther H, Buettner P, Bauer J, Garbe C (2003) Moderate sun exposure and nevus counts in parents are associated with development of melanocytic nevi in childhood. Cancer 97: 628–638.

    Google Scholar 

  33. Wachsmuth RC, Gaut RM, Barrett JH, et al. (2001) Heritability and gene –environment interactions for melanocytic nevus density examined in a UK adolescent twin study. J Invest Dermatol 117: 348–352.

    Google Scholar 

  34. Zhu G, Duffy DL, Eldridge A, et al. (1999) A major quantitative-trait locus for mole density is linked to the familial melanoma gene CDKN2A:a maximum-likelihood combined linkage and association analysis in twins and their sibs. Am J Hum Genet 65: 483–492.

    Google Scholar 

  35. Foon PW, Scheuner MT, Paterson-Oshlke KL, Gwinn M, Faucett A, Khoury MJ (2002) Can family history be used as a tool for public health and preventive medicine? Genet Med 4: 304–320.

    Google Scholar 

  36. Feightner JW (1994) Prevention of skin cancer. In:Canadian Task Force on Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa: Health Canada, pp. 850–859.

    Google Scholar 

  37. http://www. health. gov. au/nhmrc/publications/pdf/cp68. pdf

  38. US Preventive Services Task Force (2001) Screening for skin cancer:recommendations and rationale. Am J Prev Med 20:44–46.

    Google Scholar 

  39. Clegg LX, Feuer EJ, Midthune DN, Fay MP, Hankey BJ (2002) Impact of reporting delay and reporting error on cancer incidence rates and trends. J Natl Cancer Inst 94:1537–1545.

    Google Scholar 

  40. Ziogas A, Anton-Culver H (2003) Validation of family history data in cancer family registries. Am J Prev Med 24:190–198.

    Google Scholar 

  41. Aitken JF, Youl P, Green A, MacLennan R, Martin NG (1996) Accuracy of case-reported family history of melanoma in Queens-land, Australia. Melanoma Res 6:313–317.

    Google Scholar 

  42. Marrett LD, Nguyen HL, Armstrong BK (2001) Trends in the incidence of cutaneous malignant melanoma in New South Wales, 1983 –1996. Int J Cancer 92:457–462.

    Google Scholar 

  43. Gaudette LA, Gao RN (1998) Changing trends in melanoma incidence and mortality. Health Rep 10:29–41.

    Google Scholar 

  44. Buettner PG, Garbe C (2000) Agreement between self-assessment of melanocytic nevi by patients and dermatologic examination. Am J Epidemiol 151:72–77.

    Google Scholar 

  45. Harrison SL, Buettner PG, MacLemmon R, Kelly JW, Rivers JK (2002) How good are parents at assessing melanocytic nevi on their children? study comparing parental counts, dermatologist counts, and counts obtained from photographs. Am J Epidemiol 155:1128–1136.

    Google Scholar 

  46. Bain C, Colditz GA, Willett WC, et al. (1998) Self-reports of mole counts and cutaneous malignant melanoma in women: methodological issues and risk of disease. Am J Epidemiol 127: 703–712.

    Google Scholar 

  47. English DR, Armstrong BK (1994) Melanocytic nevi in children. II. Observer variation in counting nevi. Am J Epidemiol 139: 402–407.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Begg, C.B., Hummer, A., Mujumdar, U. et al. Familial aggregation of melanoma risks in a large population-based sample of melanoma cases. Cancer Causes Control 15, 957–965 (2004). https://doi.org/10.1007/s10522-004-2474-2

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10522-004-2474-2

Navigation